<DOC>
	<DOCNO>NCT00616070</DOCNO>
	<brief_summary>The purpose phase III study determine safety efficacy difluprednate management inflammation follow ocular surgery .</brief_summary>
	<brief_title>Study Difluprednate Treatment Inflammation Following Ocular Surgery ( ST-601-003 )</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<criteria>Scheduled unilateral ocular surgery . Systemic administration corticosteroid immunosuppressive drug 2 week prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>